Critical

Acute lupus pneumonitis

Severe SLE respiratory emergency · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A rare but life-threatening manifestation of SLE causing acute inflammatory alveolitis with fever, cough, dyspnoea, hypoxaemia and diffuse infiltrates. It is difficult to distinguish from infection and diffuse alveolar haemorrhage, both of which must be excluded or treated concurrently.

Red flags

  • Rapidly rising oxygen requirement / respiratory failure
  • Haemoptysis with falling haemoglobin (alveolar haemorrhage)
  • Haemodynamic instability
  • Failure to improve on antimicrobials (favours lupus pneumonitis)
  • Multi-organ lupus activity

Assessment

Differential diagnosis

  • Infective pneumonia (including opportunistic)
  • Diffuse alveolar haemorrhage
  • Pulmonary oedema / lupus cardiac disease
  • Pulmonary embolism (antiphospholipid)
  • Acute respiratory distress syndrome
  • Drug-induced pneumonitis

Investigations

  • Chest radiograph and CT chest (diffuse bilateral infiltrates)
  • ABG and continuous oxygen saturation monitoring
  • FBC (falling haemoglobin suggests alveolar haemorrhage), CRP
  • Anti-dsDNA, complement C3/C4, antiphospholipid antibodies
  • Infection screen: cultures, respiratory viral PCR, PJP work-up
  • Bronchoscopy with lavage (exclude infection; progressively bloodier returns in haemorrhage)

Management

  • Resuscitate and give oxygen; admit to HDU/ICU and support ventilation as needed
  • Exclude and empirically treat infection - it is the main mimic and may coexist
  • Look specifically for diffuse alveolar haemorrhage (falling Hb, haemoptysis, bloody lavage)
  • Confirm active lupus with serology (low complement, high anti-dsDNA)
  • Start high-dose corticosteroid once infection is covered/reasonably excluded
  • Add cyclophosphamide or rituximab for severe or steroid-refractory disease
  • Consider plasma exchange for coexistent alveolar haemorrhage/severe disease
  • Monitor gas exchange and haemoglobin; escalate immunosuppression if deteriorating

Drugs & doses

Methylprednisolone — 500 mg-1 g IV OD for 3 days then prednisolone 1 mg/kg/day
Cyclophosphamide — 500-1000 mg/m2 IV (dose-adjusted) for severe disease
Rituximab — 1 g IV days 1 and 15 as alternative induction
Co-trimoxazole — empirical cover / PJP treatment dose while infection excluded
Broad-spectrum antibiotics (e.g. piperacillin-tazobactam 4.5 g IV QDS) until infection excluded

Disposition

Admit to ICU/HDU; concurrent infection cover and high-dose immunosuppression with rheumatology, respiratory and intensive care input.

Complications & pitfalls

  • Respiratory failure and ARDS
  • Coexistent/undertreated infection
  • Diffuse alveolar haemorrhage
  • High mortality if treatment delayed
  • Pulmonary fibrosis in survivors

Exam pearls

  • Acute lupus pneumonitis, infection and alveolar haemorrhage overlap - treat infection empirically while giving immunosuppression
  • A falling haemoglobin with infiltrates points to alveolar haemorrhage
  • Low complement and high anti-dsDNA support active lupus
  • Mortality is high - do not delay high-dose steroids once infection is covered

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.